The top 20 drugmakers — led by GLP-1 manufacturers Eli Lilly and Novo Nordisk — reported a total increase of 9.6% in market capitalization in the first quarter of 2024.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,